Adjuvant atezolizumab for early triple-negative breast cancer: The ALEXANDRA/IMpassion030 randomized clinical trial.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 6
- By:
- Publication type:
- Article
Works in Breast Cancer Research Review, 2025, Issue 47
Results: 11
1
2
Clinical characteristics and survival outcomes of metastatic invasive lobular and ductal carcinoma.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 6
- By:
- Publication type:
- Article
3
Outcomes and treatment patterns for stage I human epidermal growth factor receptor 2-positive breast cancer in the Surveillance, Epidemiology, and End Results database, 2010-2019.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 5
- By:
- Publication type:
- Article
4
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: Final invasive disease-free survival results from the NATALEE trial.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 5
- By:
- Publication type:
- Article
5
Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61-20; Neo-N): A non-comparative, open-label, randomised, phase 2 trial.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 5
- By:
- Publication type:
- Article
6
Impact of resection margin width on local recurrence following breast-conserving surgery and whole breast radiotherapy for pure ductal carcinoma in situ: A systematic review and meta-analysis.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 4
- By:
- Publication type:
- Article
7
Introduction of breast density notification within BreastScreen South Australia -- Results of an online client survey.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 4
- By:
- Publication type:
- Article
8
Quantifying the influence of psychosocial characteristics, supportive care needs and quality of life on breast cancer survival.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 3
- By:
- Publication type:
- Article
9
Breast cancer-specific survival by molecular subtype in different age groups of women in Scotland.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 2
- By:
- Publication type:
- Article
10
Current pattern of care in radiation therapy for DCIS in Australia and New Zealand -- Where are we heading?
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 1
- By:
- Publication type:
- Article
11
Welcome to Issue 47 of Breast Cancer Research Review.
- Published in:
- Breast Cancer Research Review, 2025, n. 47, p. 1
- By:
- Publication type:
- Article